en

Pre-Plated Sets


Pre-Plated Sets: Format/Size Descriptions Download
Signature Libraries 2387 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
ASINEX's cutting edge chemistry combined with in silico and in vitro screening validation.
Macrocycle
Pre-Plated Set
23044 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
ASINEX ‘s Macrocycle Pre-plated Sets are designed to provide the most popular screening libraries in a convenient and cost-effective manner.
Diversity
Pre-Plated Set
119877 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
Pre-Plated Set of compounds selected from ASINEX BioDesign Libraries, Elite Libraries, Synergy Libraries, Gold&Platinum Collections.
Diversity-2
Pre-Plated Set
282478 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
Pre-Plated Set of compounds selected from ASINEX BioDesign Libraries, Elite Libraries, Synergy Libraries, Gold&Platinum Collections.
PPI Pre-Plated Set 3253 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
ASINEX has been working on the design and synthesis of protein-protein interaction (PPI) libraries since 2008. The latest generation of ASINEX PPI Library comprises molecules of various sizes, frameworks, and shapes ranging from fragment-like entities to macrocyclic derivatives designed as secondary structure mimetics or as epitope mimetics.
CNS Diversity
Pre-Plated Set
6003 compounds
Pre-Plated Set
Amount: 0.01-2.0mg
Update: 2023-10
ASINEX has selected CNS-like molecules with high diversity:
CNS-MPO > 4
CNS-MPO.v2 > 4
CNS-TEMPO < 4
Glycomimetics
Pre-Plated Set
2384 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
ASINEX has overcome these obstacles by creating a glycomimetic library that ensures the bioactive function of carbohydrates while addressing the drawbacks of carbohydrates, such as their low activity and poor drug-like properties.
Nucleoside-mimetics
Pre-Plated Set
3366 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
ASINEX has developed a number of stereo- and enantio-selective methods for the synthesis of nucleoside-like core intermediates (e. g. mimics of adenosine). These unique intermediates have been extensively decorated by various long chain amines, acids and amino acids.
Kinase Pre-Plated Set 6466 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
ASINEX facilitates the discovery of novel kinase inhibitors by providing access to our advanced collection of small molecules, fragments and macrocycles. The efficacy of our compounds has been validated through in silico modeling and in vitro on-target and phenotypic profiling. This is paralleled with 20+ years of medicinal chemistry expertise, delivering designs with outstanding ADMET and PK properties, optimizing chances in hit to candidate development.
Covalent Inhibitors
Pre-Plated Set
972 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
ASINEX has crafted a unique set of 1000 molecules containing electophylic moieties that could potentially interact with cysteine residues in the target protein. The diversity of represented scaffolds creates multiple opportunities for drug discovery in various target and therapeutic areas such as kinases, proteases, protein-protein interactions, and antimicrobials.
Targeted Oncology
Pre-Plated Set
6528 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
Immuno Oncology
Pre-Plated Set
5376 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
GPCR
Pre-Plated Set
6192 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2023-10
Contact
Global

Ludmila Sadovenko

lsadovenko@asinex.com
North America

Mark Parisi

mparisi@asinex.com

Toll Free: +1 877 ASINEX1

Tel: +1 336 721 1617

Fax: +1 336 721 1618

N.Chestnut St., Ste.104

Winston-Salem, NC 27101

USA

Europe

Galina Afanasyeva

gafanasyeva@asinex.com

Tel: +31 (0) 203416183

Klaprozenweg 75C, 1033NN

Amsterdam, The Netherlands

Cart
Your cart is empty
Order
$
0
Checkout
Thanks for your order
We will contact you shortly